Home > Qtrly Results > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Quarterly Results Analysis [Mar2026]

ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Quarterly Results

Standalone Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
Audited
Revenues ₹579 Cr ₹612 Cr ₹559 Cr ₹526 Cr ₹480 Cr ₹440 Cr ₹408 Cr ₹388 Cr
Expenses ₹518 Cr ₹567 Cr ₹484 Cr ₹445 Cr ₹394 Cr ₹363 Cr ₹355 Cr ₹349 Cr
Operating Income ₹61 Cr ₹45 Cr ₹75 Cr ₹81 Cr ₹86 Cr ₹77 Cr ₹53 Cr ₹38 Cr
Other Income ₹6 Cr ₹5 Cr ₹6 Cr ₹11 Cr ₹16 Cr ₹8 Cr ₹8 Cr ₹8 Cr
Interest ₹2 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹6 Cr ₹4 Cr ₹3 Cr ₹17 Cr ₹18 Cr ₹9 Cr ₹9 Cr ₹4 Cr
Profit Before Tax ₹58 Cr ₹47 Cr ₹73 Cr ₹75 Cr ₹78 Cr ₹42 Cr ₹51 Cr ₹-15 Cr
Profit After Tax ₹45 Cr ₹33 Cr ₹54 Cr ₹56 Cr ₹58 Cr ₹31 Cr ₹38 Cr ₹-12 Cr
EPS ₹17.95 ₹13.04 ₹21.69 ₹22.33 ₹23.30 ₹12.34 ₹15.37 ₹-4.72
Industry Peers & Returns1W1M1Y
ASTRAZENECA PHARMA INDIA -1.4% 2.7% 6.7%
SUN PHARMACEUTICAL INDUSTRIES -0.7% -3.6% 6%
DIVIS LABORATORIES 1.1% -1.2% -0.3%
TORRENT PHARMACEUTICALS 1.6% 1.4% 36.7%
CIPLA 0.7% 2.6% -4.6%
DR REDDYS LABORATORIES -0.9% -2.5% 1.2%
MANKIND PHARMA 0.7% -1.1% -4.8%
LUPIN 0.4% -7.1% 14.8%
ZYDUS LIFESCIENCES -0.2% 16% 16.7%

ASTRAZENECA PHARMA INDIA Quarterly Revenues

Revenues
Q-o-Q

-5.39 %

Y-o-Y

20.42 %

Quarters Revenues % Change
Mar2026 ₹579 Cr
-5.39
Dec2025 ₹612 Cr
9.39
Sep2025 ₹559 Cr
6.23
Jun2025 ₹526 Cr
9.54
Mar2025 ₹480 Cr
9.13
Dec2024 ₹440 Cr
7.91
Sep2024 ₹408 Cr
5.28
Jun2024 ₹388 Cr -

ASTRAZENECA PHARMA INDIA Quarterly Operating Profit

Operating Profit
Q-o-Q

35.87 %

Y-o-Y

-29.48 %

Quarters Operating Profit % Change
Mar2026 ₹61 Cr
35.87
Dec2025 ₹45 Cr
-40.37
Sep2025 ₹75 Cr
-7.31
Jun2025 ₹81 Cr
-6.09
Mar2025 ₹86 Cr
12.18
Dec2024 ₹77 Cr
46.54
Sep2024 ₹53 Cr
38.01
Jun2024 ₹38 Cr -
Operating Margins
Q-o-Q

43.66 %

Y-o-Y

-41.43 %

Quarters Operating Margin% % Change
Mar2026 10.53%
43.66
Dec2025 7.33%
-45.50
Sep2025 13.45%
-12.72
Jun2025 15.41%
-14.29
Mar2025 17.98%
2.80
Dec2024 17.49%
35.79
Sep2024 12.88%
31.16
Jun2024 9.82% -

ASTRAZENECA PHARMA INDIA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

37.71 %

Y-o-Y

-22.95 %

Quarters Profit After Tax % Change
Mar2026 ₹45 Cr
37.71
Dec2025 ₹33 Cr
-39.89
Sep2025 ₹54 Cr
-2.88
Jun2025 ₹56 Cr
-4.15
Mar2025 ₹58 Cr
88.82
Dec2024 ₹31 Cr
-19.72
Sep2024 ₹38 Cr
Positive
Jun2024 ₹-12 Cr -
PAT Margins
Q-o-Q

45.59 %

Y-o-Y

-35.97 %

Quarters PAT Margin(%) % Change
Mar2026 7.76 %
45.59
Dec2025 5.33 %
-45.05
Sep2025 9.7 %
-8.58
Jun2025 10.61 %
-12.46
Mar2025 12.12 %
72.90
Dec2024 7.01 %
-25.58
Sep2024 9.42 %
Positive
Jun2024 -3.04 % -

ASTRAZENECA PHARMA INDIA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

37.65 %

Y-o-Y

-22.96 %

Quarters EPS % Change
Mar2026 ₹17.95
37.65
Dec2025 ₹13.04
-39.88
Sep2025 ₹21.69
-2.87
Jun2025 ₹22.33
-4.16
Mar2025 ₹23.3
88.82
Dec2024 ₹12.34
-19.71
Sep2024 ₹15.37
Positive
Jun2024 ₹-4.72 -

You may also like the below Video Courses